Methods and dressings for sealing internal injuries
AssigneeSTB, Ltd.
InventorsMartin MACPHEE, Jerry KANELLOS, Belinda WILMER, Dawson BEALL
Life of this patent
Estimating the term…
Abstract
Disclosed are solid and frozen haemostatic materials and dressing's consisting essentially of a fibrinogen component and a fibrinogen activator. Also disclosed are methods of treating internal wounded tissue in a mammal by applying one or more of these haemostatic materials and dressings.
Claims20
A method for treating wounded internal tissue in a mammal comprising applying to wounded internal tissue at least one haemostatic material consisting essentially of a fibrinogen component and a fibrinogen activator for a time sufficient to join or approximate said wounded tissue and/or to reduce the flow of fluid from said wounded tissue, wherein said haemostatic material has a plurality of particles, wherein said particles each have the same composition, and wherein the moisture content of said hemostatic material is from 6% to 44%.
A method for treating wounded internal tissue in a mammal comprising applying to wounded internal tissue at least one haemostatic material consisting essentially of a fibrinogen component and a fibrinogen activator for a time sufficient to join or approximate said wounded tissue and/or to reduce the flow of fluid from said wounded tissue, wherein said haemostatic material has a plurality of particles, wherein said particles each have the same composition, and wherein the moisture content of said hemostatic material is from 1% to 6%.
A method for treating wounded internal tissue in a mammal comprising applying to svounded internal tissue at least one haemostatic material consisting essentially of a fibrinogen component and a fibrinogen activator for a time sufficient to join or approximate said wounded tissue and/or to reduce the flow of fluid from said wounded tissue, wherein said haemostatic material is cast or formed as a single piece.
20-44. (canceled)
Dependencies are inferred from the claim text.